Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

BACKGROUND: Low absolute lymphocyte count (ALC) has previously been established as a marker of poor prognosis in multiple cancer types. There is growing evidence that ALC may also be associated with response to immunotherapy. This study explores whether response to PD1 inhibitors in recurrent and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Won Jin, Yarchoan, Mark, Hopkins, Alex, Mehra, Ranee, Grossman, Stuart, Kang, Hyunseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117944/
https://www.ncbi.nlm.nih.gov/pubmed/30170629
http://dx.doi.org/10.1186/s40425-018-0395-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117944/
https://www.ncbi.nlm.nih.gov/pubmed/30170629
http://dx.doi.org/10.1186/s40425-018-0395-x

Ejemplares similares